Description
Description
Blue capsules No. 2 or No. 4 (for a dosage of 30 mg), red capsules No. 2 or No. 3 (for a dosage of 90 mg).
The capsule lid has a white logo in the form of a ring and the letter AND inside the ring.
The contents of the capsules ² granules and white or almost white powder ² conglomerates are allowed to form, easily crumbling with light pressure.
Indications
Treatment and prevention of influenza A and B and other acute respiratory viral infections (adenovirus infection, parainfluenza, respiratory syncytial infection, rhinovirus infection) in adults and children from 3 years.
Contraindications
Hypersensitivity to the active substance or any other component of the drug.
Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.
Pregnancy.
Breastfeeding period.
Children under 3 years old.
Use during pregnancy and lactation
The use of the drug during pregnancy has not been studied.
The use of the drug during lactation has not been studied, so if you need to use the drug during lactation, you should stop breastfeeding.
Special instructions
Concomitant use of other antiviral drugs is not recommended without first consulting a doctor.
The effect on the ability to drive vehicles, mechanisms has not been studied, however, given the mechanism of action and the profile of adverse reactions, it can be assumed that the drug does not affect the ability to drive vehicles, mechanisms.
Composition of
One capsule contains:
active substance:
Imidazolylethanamide pentanedioic acid (vitaglutam) in terms of 100% substance – 60.00 mg
excipients:
lactose monohydrate, srdl potassium sildylcryl potassium sulfdylcdryl
magnesium stearate
hard gelatine capsules:
titanium dioxide E 171,
dye iron oxide yellow E 172,
gelatin
logo ink composition:
shellac,
propylene glycol E 15201
drdfldf1505
drdfld1505 srdldprdfld150 srdldprdfld150 srdlrd soder living:
active substance:
imidazolylethanamide pentanedioic acid (vitaglutam) in terms of 100% substance – 30.00 mg or 90.00 mg
excipients:
lactose monohydrate,
potato starch,
silica colloid dioxide (aerosil) solid strc :
for a dosage of 30 mg:
titanium dioxide E 171, dye black E 151, blue dye patent E 131, dye crimson [Ponceau 4 R] E 124, dye azorubine E 122, gelatin
for a dosage of 90 mg:
titanium dioxide E 171, crimson dye [Ponceau 4 R] E 124, red Tel azorubin E 122 colorant quinoline yellow E 104 Gelatin
ink composition for logotype: shellac, propylene E 1520, titanium dioxide E 171.
Dosage and Administration
Inside. Regardless of the meal.
In children from 3 to 6 years old who have difficulty swallowing the capsule, dilution of the contents of the capsule in water or apple juice is allowed. To do this, gently open the capsule above the container with a small amount (50-70 ml) of boiled water or apple juice at room temperature, pour the contents of the capsule into water or juice, mix the mixture for 20 seconds and drink it whole.
Sugar added. The mixture should be prepared immediately before administration. The finished mixture should not be stored. For the treatment and prevention of influenza and acute respiratory viral infections, adults are prescribed 90 mg once a day, children from 7 years old – 60 mg once a day, children from 3 to 6 years old – 30 mg once a day.
The duration of treatment for influenza and acute respiratory viral infections in adults and children from 7 years of age is 5-7 days (depending on the severity of the condition). The duration of treatment for influenza and acute respiratory viral infections in children from 3 to 6 years is 5 days. Taking the drug begins with the onset of the first symptoms of the disease, preferably no later than 2 days from the onset of the disease.
For the prevention of influenza and acute respiratory viral infections after contact with sick adults and children from 7 years of age, the drug is prescribed for 7 days, for children from 3 to 6 years – for 5 days.
If, after 5 days of treatment, improvement does not occur or the symptoms worsen, or new symptoms appear, consult a doctor. Use the drug only according to the indications, the method of use and at the doses indicated in the instructions.
Side effects
Allergic reactions (rare).
If any of the side effects indicated in the instructions are aggravated or you notice any other side effects not listed in the instructions, inform your doctor.
Drug Interactions
Drug interactions with Ingavirin ® have not been described.
Overdose
Cases of overdose of the drug Ingavirin ® to date not reported.
Storage Conditions
In a dark place at a temperature not exceeding 25 ° C.
Keep out of the reach and sight of children.
Term hodnosty
3 years
active substance
Imidazoliletanamid pentandiovoy acid
lekarstvennaja form
kapsul
